Sign up to our newsletter Subscribe
Understanding the Full Value of Long-Acting Therapies: less is more?
Trending
We provide independent and pioneering resources, research and analyses
Our work in health economics, health policy and health statistics informs decision-making about health care and pharmaceutical issues at a global level.
0
%
of rare diseases have a single-gene cause
0
%
is the likelihood of developing dementia, becoming an informal carer, or both in a lifetime
0
%
of the NHS’s total carbon footprint accounts for the manufacture, supply, and use of pharmaceuticals
0
clinical trials supported the first digital therapeutic recommended by NICE
